Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
Exelixis (EXEL)
- 54.390
- +1.270+2.39%
Close Aug 19 16:00 ET
- 54.190
- -0.200-0.37%
Post 16:33 ET
13.48BMarket Cap17.10P/E (TTM)
54.580High53.100Low2.48MVolume53.460Open53.120Prev Close134.86MTurnover1.16%Turnover Ratio19.56P/E (Static)247.78MShares57.57052wk High7.31P/B11.65BFloat Cap33.75552wk Low--Dividend TTM214.12MShs Float57.570Historical High--Div Yield TTM2.79%Range %1.260Historical Low54.296Avg Price1Lot Size
Exelixis (EXEL) News
BMO Capital Initiates Coverage On Exelixis With Market Perform Rating, Announces Price Target of $54
Quant Ratings on Renaissance Technologies Top Holdings: NVDA, META, INTC
Here's Why We Think Exelixis (NASDAQ:EXEL) Is Well Worth Watching
Exelixis Earnings Call: Cabo Strength, Zanza Awaited
Guggenheim Keeps Their Hold Rating on Exelixis (EXEL)
Express News | Exelixis Inc : Leerink Partners Cuts Target Price to $52.00 From $55.00
Exelixis Targets Residual Colorectal Cancer With New Phase 3 Trial
Truist Securities Maintains Hold on Exelixis, Lowers Price Target to $52
Goldman Sachs Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $64
Analysts' Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)
Stifel Maintains Hold on Exelixis, Raises Price Target to $51
RBC Capital Sticks to Their Hold Rating for Exelixis (EXEL)
Express News | Exelixis, Inc. : Wells Fargo Raises Target Price to $50 From $49
Exelixis: Buy Rating Reaffirmed on Cabozantinib Resilience, Cost Discipline and Zanzalintinib Upside Despite Near-Term NET Guidance Cut
BofA Securities Maintains Exelixis(EXEL.US) With Sell Rating, Maintains Target Price $41
Bank of America Securities Reaffirms Their Sell Rating on Exelixis (EXEL)
William Blair Maintains Exelixis(EXEL.US) With Buy Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA), Exelixis (EXEL) and Editas Medicine (EDIT)
Express News | Exelixis Outlook FY Revenue USD 2,500-2,550 Million
Exelixis Q2 Adjusted Earnings, Revenue Rise; Shares Drop After Hours
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm